Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-021-03696-2
Abstract: BRCA1/2 screening for all triple-negative breast cancer (TNBC) patients younger than 60 years may still be an economic burden in China. Further evidences that include incidence and outcome of BRCA1/2 pathogenic variants (PV) screened based…
read more here.
Keywords:
germline tumor;
brca1;
tumor brca1;
triple negative ... See more keywords